GEMPACRA
Hold
Pakistan Credit Rating Agency Share Price Today, Live PSX Chart & Forecast (PSX: GEMPACRA) The Pakistan Credit Rating Agency Ltd
Open
Rs 34.01
High
Rs 37.40
Low
Rs 34.01
Prev close
Rs 37.40
Volume
310
Turnover
Rs 0.0M
AI verdict · rule-engine-v2
Hold
45% confidence · Medium Term
Our model is neutral on GEMPACRA. It has called this stock correctly 42.7% of the time over 117 out-of-sample checks. See what drove this ↓
Target
Rs 37.40
Exp. return
+0.0%
GEMPACRA share price and analysis
The Pakistan Credit Rating Agency Ltd (GEMPACRA) last traded at Rs 37.40 on the Pakistan Stock Exchange, where it closed unchanged on the session of 7 September 2026. Only 310 shares, a turnover of Rs 11,594 changed hands — a nominal amount, at which a single order moves the quoted price and the close is not a reliable mark. Over the past year the share has traded between Rs 16.55 and Rs 49.00, putting the current price around the middle of that range.
The price is between its 20-day (39.53) and 50-day (35.10) moving averages, so the short-term trend is unresolved. The 14-day RSI is 50.4, a neutral reading. ADX at 22.6 indicates a weak or rangebound trend.
The company is capitalised at roughly Rs 2.8 billion and is classified under Pharmaceuticals. It trades on a price-to-earnings ratio of 16.6, meaning the market is paying about Rs 16.6 for every rupee of annual earnings. Earnings per share stand at Rs 1.71. The trailing dividend yield is 2.10%, which is the income a holder receives at the current price before any capital movement. Return on equity is 15.3%. A beta of 1.17 means the share has historically moved more sharply than the wider market.
GEMPACRA ranks 19th of 30 Pharmaceuticals companies by market value. Its price-to-earnings ratio of 16.6 compares with the Pharmaceuticals median of 15.5, putting it broadly in line with its sector. Its trailing dividend yield of 2.10% sits below the 3.36% median for the sector. Sector medians are taken across the companies we hold fundamentals for and move as those are restated.
Our forecasting model currently reads GEMPACRA as hold over a medium term horizon, at 45% confidence. Its target price is Rs 37.40, an expected return of +0.0%. The model is computed from the price and indicator history shown on this page. It does not read news, financial statements or management changes, and it is not a recommendation to buy or sell.
This summary is generated from the end-of-day prices and indicators shown on this page and is refreshed after each trading session. It describes the data; it is not a recommendation. See how we collect and check this data and our disclaimer.
GEMPACRA technical indicators — RSI, MACD & moving averages
Price chart
RSI (14)
MACD (12, 26, 9)
RSI 14
50.4
Stoch %K
42.4
ADX 14
22.6
Williams %R
-57.6
SMA 20
39.53
SMA 50
35.10
MACD
0.005
ATR 14
1.881
BB Upper
48.96
BB Lower
30.09
Momentum
1.38
Tech score
51
GEMPACRA AI forecast & accuracy
rule-engine-v2directional accuracy over 117 backtested 10-day forecasts on this stock's history
- Target
- Rs 37.40
- Stop
- —
- Support
- Rs 32.52
- Resistance
- Rs 49.00
- Exp. return
- 0.00%
- Risk
- 78.52/100
Why
GEMPACRA is in a neutral, range-bound state. Overall score 51/100. Drivers: Price above the 50-day average (uptrend); Histogram negative — momentum fading; Weak/ranging trend (ADX 23); Fundamental score 48/100. Suggested action: Hold and wait for a clearer trend or momentum trigger. This is an automated model assessment, not financial advice.
Generated by rule-engine-v2 from the indicators above. It does not read news, filings or management changes — see how this works.
GEMPACRA fundamentals & valuation ratios
- Market cap
- Rs 2.8B
- P/E
- 16.6
- EPS
- 1.71
- P/B
- 3.1
- Div yield
- 2.10%
- ROE
- 15.3%
- Beta
- 1.17
- Volatility
- 82.1%
GEMPACRA price history — last 30 sessions
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Mon, 7 Sep 2026 | 34.01 | 37.40 | 34.01 | 37.40 | +0.00% | 310 |
| Fri, 4 Sep 2026 | 36.75 | 37.40 | 36.75 | 37.40 | +1.77% | 5,000 |
| Wed, 2 Sep 2026 | 35.11 | 36.75 | 35.11 | 36.75 | +4.67% | 2,500 |
| Tue, 1 Sep 2026 | 39.00 | 39.00 | 35.11 | 35.11 | -9.97% | 4,500 |
| Fri, 21 Aug 2026 | 35.75 | 39.00 | 35.75 | 39.00 | +9.09% | 1,000 |
| Fri, 7 Aug 2026 | 35.75 | 35.75 | 35.75 | 35.75 | +0.00% | 1 |
| Wed, 5 Aug 2026 | 35.75 | 35.75 | 35.75 | 35.75 | +0.00% | 100 |
| Fri, 31 Jul 2026 | 35.75 | 35.75 | 35.75 | 35.75 | +0.00% | 210 |
| Thu, 30 Jul 2026 | 32.52 | 35.75 | 32.52 | 35.75 | +9.93% | 41,800 |
| Tue, 28 Jul 2026 | 36.02 | 36.02 | 32.52 | 32.52 | -9.72% | 61,000 |
| Mon, 27 Jul 2026 | 39.61 | 39.61 | 36.02 | 36.02 | -9.06% | 41,000 |
| Tue, 21 Jul 2026 | 39.61 | 39.61 | 39.61 | 39.61 | +0.00% | 101 |
| Tue, 14 Jul 2026 | 39.61 | 39.61 | 39.61 | 39.61 | +0.00% | 1 |
| Thu, 9 Jul 2026 | 44.02 | 44.02 | 39.61 | 39.61 | -10.02% | 1,001 |
| Mon, 6 Jul 2026 | 49.00 | 49.00 | 44.02 | 44.02 | -10.16% | 2,030 |
| Wed, 1 Jul 2026 | 49.00 | 49.00 | 49.00 | 49.00 | +0.00% | 20 |
| Tue, 30 Jun 2026 | 47.90 | 49.00 | 47.90 | 49.00 | +2.30% | 19,284 |
| Mon, 29 Jun 2026 | 43.86 | 47.90 | 43.86 | 47.90 | +9.21% | 10,100 |
| Wed, 24 Jun 2026 | 40.72 | 43.86 | 40.72 | 43.86 | +7.71% | 1,350 |
| Tue, 23 Jun 2026 | 41.52 | 41.52 | 40.72 | 40.72 | -1.93% | 300 |
| Mon, 22 Jun 2026 | 37.85 | 41.52 | 37.85 | 41.52 | +9.70% | 2,699 |
| Fri, 19 Jun 2026 | 38.72 | 38.72 | 37.85 | 37.85 | -2.25% | 700 |
| Thu, 18 Jun 2026 | 35.20 | 38.72 | 35.20 | 38.72 | +10.00% | 4,680 |
| Wed, 17 Jun 2026 | 32.00 | 35.20 | 32.00 | 35.20 | +10.00% | 1,674 |
| Tue, 9 Jun 2026 | 32.00 | 32.00 | 32.00 | 32.00 | +0.00% | 940 |
| Fri, 5 Jun 2026 | 32.00 | 32.00 | 32.00 | 32.00 | +0.00% | 60 |
| Wed, 3 Jun 2026 | 33.11 | 33.11 | 32.00 | 32.00 | -3.35% | 29,445 |
| Tue, 2 Jun 2026 | 33.49 | 33.49 | 33.11 | 33.11 | -1.13% | 2,511 |
| Mon, 1 Jun 2026 | 33.49 | 33.49 | 33.49 | 33.49 | +0.00% | 72 |
| Fri, 29 May 2026 | 33.51 | 33.51 | 33.49 | 33.49 | -0.06% | 1,016 |
All figures in PKR, end of day, sourced from the Pakistan Stock Exchange.
Other Pharmaceuticals stocks
GEMPACRA is a Pharmaceuticals listing. Compare it against the rest of the sector, or read what actually drives Pharmaceuticals companies on the PSX.
All Pharmaceuticals shares on the PSX →Learn how to read this page
-
How to Read a Stock Page Without Fooling Yourself
A walk through every number on a PSX stock page — price, volume, P/E, RSI, our own AI signal — and an honest account of how much weight each one deserves.
-
Technical Analysis on the PSX: Using Moving Averages, RSI and MACD Without Fooling Yourself
Moving averages, RSI and MACD describe past prices — nothing more. Used in the right order they keep you honest; used as signals they lose money. Here are the mechanics that actually work on the PSX, and where thin volume and circuit breakers make indicators meaningless.
-
How to Read a PSX Company's Financial Statements
Annual reports are free, audited and almost never read. A walk through a PSX income statement and balance sheet, with EPS, P/E, ROE and dividend yield worked by hand — and the red flags those ratios quietly hide.
GEMPACRA — frequently asked questions
What is GEMPACRA's share price today?
+
The Pakistan Credit Rating Agency Ltd (GEMPACRA) last traded at Rs 37.40 on the Pakistan Stock Exchange, unchanged on the session of 7 September 2026. The day's range was Rs 34.01 to Rs 37.40 on 310 shares. These are end-of-day figures published by the exchange, not a live trading feed.
What is the 52-week high and low for GEMPACRA on the PSX?
+
GEMPACRA has traded between Rs 16.55 and Rs 49.00 over the past twelve months on the Pakistan Stock Exchange. The range is computed from the end-of-day closes we hold for the stock and is refreshed after every session.
What is GEMPACRA's current dividend yield?
+
GEMPACRA has a trailing dividend yield of 2.10%, meaning that for every Rs 100 invested at the current price a holder received about Rs 2.10 in dividends over the last twelve months. Yield moves with the share price as well as with the payout, so a rising yield is not automatically a better income stream.
Is GEMPACRA Shariah-compliant on the PSX?
+
Yes. The Pakistan Stock Exchange lists GEMPACRA in its Shariah-screened KMI All Share index, which means the company passed the screening set with Meezan Bank at the last review — the business-activity test plus the financial ratio tests on interest-bearing debt, illiquid assets and non-compliant income. Screening is periodic, so a company can be dropped when a ratio breaks; check the current KMI index membership before relying on it.
Which PSX indices is GEMPACRA part of?
+
GEMPACRA is a constituent of the KSE All Share and KMI All Share. It is not in the KSE-100, the headline PSX benchmark. Index membership is taken from the exchange's own published listing for each session.
Is GEMPACRA expensive? What are its valuation ratios?
+
GEMPACRA trades on a price-to-earnings ratio of 16.6, so the market is paying about Rs 16.6 for each rupee of annual earnings, earnings per share of Rs 1.71, a price-to-book ratio of 3.08 and a return on equity of 15.3%. Ratios are only meaningful next to the rest of the sector — a low multiple that the whole sector shares is usually a sector problem rather than a bargain, which is why the sector page is linked from this one.
What is the AI forecast for GEMPACRA?
+
Our model currently reads GEMPACRA as hold over a medium term horizon, at 45% confidence, with a target price of Rs 37.40. It is computed from this stock's own price and indicator history. It does not read news, financial statements or management changes, its backtested hit rate on this specific stock is published on the page, and it is not investment advice.
Answers are generated from the end-of-day figures on this page and refreshed after each session. See all frequently asked questions or our methodology.
About this data
Prices, volumes and indicators for GEMPACRA are end-of-day figures collected from the Pakistan Stock Exchange and recomputed after each session — they are not a live trading feed and may lag the market. Forecasts are the output of logistic-v1, an automated logistic-regression model trained on price history alone; it does not read news, filings or management changes, no analyst reviews its output before publication, and its track record is published in full on our model accuracy page.
PSX Expert is an independent analytics publisher. We are not licensed by the SECP as a securities adviser, investment adviser, research analyst or broker-dealer, and nothing on this page is a personal recommendation. Past performance and back-tested results do not predict future results. Read our methodology, who we are and the full disclaimer before acting on anything here.